IMMUNITYBIO, INC. Earnings Per Share (Basic)
IMMUNITYBIO, INC. (IBRX) reported Earnings Per Share (Basic) of -$0.22 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-04
- IMMUNITYBIO, INC. earnings per share, basic for the quarter ending 2026-06-30 was -$0.22.
- IMMUNITYBIO, INC. earnings per share, basic for the quarter ending 2026-03-31 was -$0.62.
- IMMUNITYBIO, INC. earnings per share, basic for the quarter ending 2025-12-31 was -$0.06.
- IMMUNITYBIO, INC. earnings per share, basic for the quarter ending 2025-09-30 was -$0.07.
- IMMUNITYBIO, INC. earnings per share, basic for fiscal 2025 was -$0.38.
- IMMUNITYBIO, INC. earnings per share, basic for fiscal 2024 was -$0.59.
- IMMUNITYBIO, INC. earnings per share, basic for fiscal 2023 was -$1.15.
- IMMUNITYBIO, INC. earnings per share, basic for fiscal 2022 was -$1.04.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$0.22 10-Q · filed 2026-08-04 | -$0.83 10-Q · filed 2026-08-04 | -$0.90 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.99 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2026-03-31 | -$0.62 10-Q · filed 2026-05-07 | -$0.69 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.77 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.89 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-12-31 | -$0.06 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$0.13 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.38 10-K · filed 2026-02-23 |
| 2025-09-30 | -$0.07 10-Q · filed 2025-11-05 | -$0.17 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.32 10-Q · filed 2025-11-05 | -$0.41 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-06-30 | -$0.10 10-Q · filed 2026-08-04 | -$0.26 10-Q · filed 2026-08-04 | -$0.34 derived: net income ÷ weighted average shares · filed 2026-08-04 | -$0.46 derived: net income ÷ weighted average shares · filed 2026-08-04 |
| 2025-03-31 | -$0.15 10-Q · filed 2026-05-07 | -$0.24 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.36 derived: net income ÷ weighted average shares · filed 2026-05-07 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-05-07 |
| 2024-12-31 | -$0.08 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$0.20 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$0.40 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$0.59 10-K · filed 2026-02-23 |
| 2024-09-30 | -$0.12 10-Q · filed 2025-11-05 | -$0.32 derived: net income ÷ weighted average shares · filed 2025-11-05 | -$0.52 10-Q · filed 2025-11-05 | -$0.86 derived: net income ÷ weighted average shares · filed 2026-02-23 |
| 2024-06-30 | -$0.20 10-Q · filed 2025-08-05 | -$0.40 10-Q · filed 2025-08-05 | -$0.74 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$0.95 derived: net income ÷ weighted average shares · filed 2026-02-23 |
| 2024-03-31 | -$0.20 10-Q · filed 2025-05-12 | -$0.55 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$0.75 derived: net income ÷ weighted average shares · filed 2026-02-23 | |
| 2023-12-31 | -$0.35 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$0.56 derived: net income ÷ weighted average shares · filed 2026-02-23 | -$1.15 10-K · filed 2026-02-23 | |
| 2023-09-30 | -$0.19 10-Q · filed 2024-11-12 | -$0.77 10-Q · filed 2024-11-12 | ||
| 2023-06-30 | -$0.32 10-Q · filed 2024-08-12 | -$0.59 10-Q · filed 2024-08-12 | ||
| 2023-03-31 | -$0.27 10-Q · filed 2024-05-09 | |||
| 2022-12-31 | -$1.04 10-K · filed 2025-03-03 | |||
| 2022-09-30 | -$0.28 10-Q · filed 2023-11-09 | -$0.77 10-Q · filed 2023-11-09 | ||
| 2022-06-30 | -$0.24 10-Q · filed 2023-08-08 | -$0.50 10-Q · filed 2023-08-08 | ||
| 2022-03-31 | -$0.26 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$0.89 10-K · filed 2024-03-19 | |||
| 2021-09-30 | -$0.22 10-Q · filed 2022-11-09 | -$0.66 10-Q · filed 2022-11-09 | ||
| 2021-06-30 | -$0.23 10-Q · filed 2022-08-08 | -$0.44 10-Q · filed 2022-08-08 | ||
| 2021-03-31 | -$0.21 10-Q · filed 2022-05-10 | |||
| 2020-12-31 | -$0.59 10-K · filed 2023-03-01 | |||
| 2020-09-30 | -$0.17 10-Q · filed 2021-11-12 | -$0.41 10-Q · filed 2021-11-12 | ||
| 2019-12-31 | -$0.43 10-K · filed 2022-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |